Company

Applied Biomics, Inc. is a Proteomics Service company established in 2005. We are centrally located in the San Francisco Bay Area, and occupy over 5,000 sq ft of lab and office spaces. We are dedicated to providing top-quality, cost-effective and full-line proteomics services to meet our customers’ research and discovery needs.

We cover both major platforms of proteomics: Gel-based 2D DIGE (2-dimensional differential in-gel electrophoresis) and Mass Spectrometry based LC-MS/MS. Our proteomics services start from customized experimental design, sample preparations, protein separations/quantifications, protein identifications to publication-ready data. Our proprietary sample preparation procedures have been optimized for every sample type. Both LC-MS/MS and 2D DIGE are powerful platforms for studying proteins biomarkers, PTMs, HCP antibody coverage, HCP profiling, and more.

Why choose us?

  • Track record: Over 450 peer-reviewed publications have cited our services
  • Quick turnaround: One week for most services
  • Cost effective: Price covers from sample preparation to publication-ready data
  • Custom experimental design: Each project is catered to achieve its specific goal, with proprietary sample preparation
  • Trusted support: All project leaders are PhD scientists who perform the experiments and communicate with customers directly
  • In-house services: All services are performed from start to end in our Bay Area lab facilities
  • Extensive experience: We have served over 5000 customers from universities, government, biotech, and pharmaceuticals

Thousands of scientists from academic, industrial and clinical laboratories have used our services to facilitate their researches in the following fields:

  • Determining HCP antibody coverage and detecting HCP contaminants
  • Improving product purification process
  • Identifying therapeutic or diagnostic markers in different diseases
  • Identifying antigens or auto-antigens from tissues and cells
  • Identifying key regulators in major biological pathways
  • Studying post-translational modifications such as phosphorylation, glycosylation and others
  • Validating drug targets